While SAHA, a well-known HDAC inhibitor, has been previously reported to cooperate with TRAIL41 and the antitumor role of protein kinase HASPIN has been established42,43, chaetocin has not been studied in relation to TRAIL in GBM. Here, HDAC9 is linked to glioblastoma.